Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
Przuntek H, Bittkau S, Bliesath H, Büttner U, Fuchs G, Glass J, Haller H, Klockgether T, Kraus P, Lachenmayer L, Müller D, Müller T, Rathay B, Sgonina J, Steinijans V, Teshmar E, Ulm G, Volc D.
Przuntek H, et al. Among authors: muller d, muller t.
Arch Neurol. 2002 May;59(5):803-6. doi: 10.1001/archneur.59.5.803.
Arch Neurol. 2002.
PMID: 12020263
Clinical Trial.